The low mean number of angina attacks at baseline may explain that we did not reach statistical significance for the reduction of angina attacks.
← all excerpts
Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.
1
—
—